Patent · US Expired

Highly purified factor VIII complex

US6307032A · kind A · utility

6Cited by

0References

29Claims

0Family size

Assignee

Baxter Aktiengesellschaft · AT

Inventors

Wolfgang Schönhofer · St. Pölten, AT
Johann Eibl · Wien, AT
Alfred Weber · Wien, AT
Yendra Linnau · Wien, AT

Key dates

Filing date	Nov 18, 1998
Grant date	Oct 23, 2001
Priority date	—
Expiry date	Nov 18, 2018

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is disclosed a highly purified complex comprising the components factor VIII and vWF having a specific activity of at least 70, preferably 100 to 300 U factor VIII:C/mg, a stable pharmaceutical preparation containing this complex as well as a method of producing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.